This product is no longer sold by ETHEX
under this NDC number. The product information below is
provided for your information only. ETHEX has received FDA approval on
Oxycodone HCl Tablets, 5mg CII
and is now manufacturing and selling it under NDC# 58177-625-04

Oxycodone HCl Tablets, 5mg CII



NDC Code

58177-0315-04

Product Category
   
 

Compare our labeled
active ingredients
to those on the
label of

   
Roxicodone™ Tablets (Roxane Laboratories) 

Dosage Strength(s)
   
Oxycodone HCl, 5mg

Package Size
   
100's

Case Quantity
   
12

Color/Shape
   
Orange Tablet with "ETH" and "315" on other side

TE Rating
   
NR (Not-Rated)

The FDA has not required that Oxycodone HCl Tablets, 5mg CII or Roxicodone™ Tablets (Roxane Laboratories) be approved for therapeutic equivalence or rated for therapeutic equivalence. Oxycodone HCl Tablets, 5mg CII is not the subject of an FDA approval. Even when products are labeled as containing the same active ingredients, they may be subject to different potency specifications and may contain different inactive ingredients. State law governs the substitution of prescription pharmaceuticals.

For further information about this product please see our product insert sheet (PDF download).


If you have additional product questions, please contact ETHEX. For product legal information please see our disclaimer.

Images shown are not actual size.

 



 

Product Search


PRODUCT NAME:
COMPARE TO:

PDFs documents can be read using the Adobe Acrobat Reader, a free download.

New Products
Cardiovascular
Pain Management
Cough/Cold & Allergy
Antianxiety
Other
FAQs
Sales Information
EDI Information
KV Pharmaceutical Technology

©2010 ETHEX Corporation. All Rights Reserved.